The Receptor for Advanced Glycation Endproducts (RAGE) and Its Ligands S100A8/A9 and High Mobility Group Box Protein 1 (HMGB1) Are Key Regulators of Myeloid-Derived Suppressor Cells

SIMPLE SUMMARY: Cancer immunotherapies using antibodies and genetically modified T cells are effective in a subset of cancer patients. However, many cancer patients do not respond to immunotherapy because their cancers induce cells called myeloid-derived suppressor cells (MDSCs) that antagonize the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ostrand-Rosenberg, Suzanne, Huecksteadt, Tom, Sanders, Karl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954573/
https://www.ncbi.nlm.nih.gov/pubmed/36831371
http://dx.doi.org/10.3390/cancers15041026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954573/
https://www.ncbi.nlm.nih.gov/pubmed/36831371
http://dx.doi.org/10.3390/cancers15041026

Ejemplares similares